BridgeMD
New treatment option for Migraine Disorders
Official title Treatment of Episodic Migraine With AURICular Neuromodulation
ClinicalTrials.gov ID: NCT06623188
What this study is testing
- What it's testing
- Migraine is a ubiquitous pathology affecting approximately 1 billion individuals and being the leading cause of morbidity worldwide before the age of 50. Migraine treatment consists of two main approaches: acute treatment to relieve headache symptoms and preventive treatment to reduce the frequency of migraine attacks by at least 50%.
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- 18 years ≥ Aged ≤ 60 years
- Moderate to severe Migraine for at least one year
- Migraines appeared before the age of 50 and diagnosed according to IHS (international headache society) criteria.
- Therapeutic failure of at least 2 migraine preventive medications
- Frequency of migraine days ≥ 4 per month and \< 15 per month
You likely can't join if
- Pathology of the auricle (e.g. epithelioma)
- Patient treated with botulinum toxin for migraine ≤ 2 months
- Patient treated with anti-cgrp for migraine, with last injection less than 3 months ago
- Patient treated with non-invasive auricular stimulation ( TENS)
The study team makes the final eligibility decision.
Where it's taking place
- Marseille, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Marseille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.